Makers Laboratories Share Price

BSE
MAKERSL •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Makers Laboratories Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52.52% Gain from 52W Low
3.8
TTM PE Ratio
Below industry Median
18.9
Price to Book Ratio
Low in industry
0.9
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.1

Makers Laboratories Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Revenue
QuarterlyYearly
Sep 2024 - 29.57 Cr Mar 2024 - 105.92 Cr
Jun 2024 - 29.59 Cr Mar 2023 - 103.55 Cr
Mar 2024 - 27.81 Cr Mar 2022 - 129.81 Cr
Dec 2023 - 26.51 Cr Mar 2021 - 69.6 Cr
Sep 2023 - 25.06 Cr - Cr
Net Profit/Loss
QuarterlyYearly
Sep 2024 - 9.76 Cr Mar 2024 - -4.81 Cr
Jun 2024 - -0.7 Cr Mar 2023 - -2.19 Cr
Mar 2024 - -0.96 Cr Mar 2022 - 11.72 Cr
Dec 2023 - -1.06 Cr Mar 2021 - 1.35 Cr
Sep 2023 - -1.13 Cr - Cr

Makers Laboratories Ltd shareholding Pattern

Promoter
61.3%
Public
38.3%
Promoter
61.3%
Public
38.4%
Promoter
61.3%
Public
38.3%
Promoter
61.3%
Public
38.4%
Promoter
61.3%
Public
38.3%
Promoter
61.3%
Public
38.3%

Makers Laboratories Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
159.00
10Day EMA
156.60
12Day EMA
155.80
20Day EMA
154.00
26Day EMA
153.50
50Day EMA
152.40
100Day EMA
148.80
200Day EMA
142.00
5Day SMA
158.50
10Day SMA
156.70
20Day SMA
151.70
30Day SMA
150.40
50Day SMA
153.20
100Day SMA
149.20
150Day SMA
144.10
200Day SMA
139.90
Delivery & Volume
Day
Combined Delivery Volume- 3419 Rs
NSE+BSE Traded Volume- 6545 Rs

Week
Combined Delivery Volume- 4490 Rs
NSE+BSE Traded Volume- 7648 Rs

Month
Combined Delivery Volume- 2536 Rs
NSE+BSE Traded Volume- 4157 Rs

Resistance & Support
159.82
Pivot
Resistance
First Resistance
163.33
Second Resistance
166.52
Third Resistance
170.03
Support
First Support
156.63
Second support
153.12
Third Support
149.93
Relative Strength Index
56.03
Money Flow Index
69.78
MACD
2.39
MACD Signal
0.86
Average True Range
10.76
Average Directional Index
20.19
Rate of Change (21)
7.56
Rate of Change (125)
14.39

Makers Laboratories Ltd Company background

Founded in: 1984
Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company is presently in manufacture of pharmaceutical formulations and drug intermediates.Makers Drugs Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993. As per terms of the scheme of amalgamation, the Company allotted 3,02,700 equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL.During 199697, MLL enhanced its installed capacity of Tablets/Capsules from 3000 to 3175 lacs and Oral/Liquids/Dry Syrups from 420000 to 500000 Ltrs and Ointments/Creams/External Liquids from 107000 to 120000 Kgs/Lit.MLL has gone for expansion in the year 1999. It has increased the installed capacity of Tablets Capsules by 13.25 crores(Nos) and the company has again expanded the installed capacity of Tablets Capsules in the year 2000 by 15.00 crores(Nos),taking the total capacity to 60.00 crores.The Modernisation of Formulation Drugs which was undertaken during 19992000 was completed successfully and this project was financed through Rights Issue of Equity Shares.The Palghar Plant Liquid Department was upgraded under the standard of schedule M during 2004. The Company sold its unviable formulations manufacturing unit at Palghar, in Thane Dist. during 2008. Harleystreet Pharmaceuticals Ltd. was merged with the Company by a Scheme of Amalgamation during the period 2011. In terms of the said Scheme of Amalgamation, 571,440 Equity shares of the Company of Rs 10/ each fully paid up were issued to the shareholders of HPL in the ratio of 6 fully paid up equity shares of Rs. 10/ each of the Company for every 10 fully paid up equity shares of Rs. 10/ each of HPL. i.e., 6:10. The Company sold its bulk drugs manufacturing unit at Dombivili, in Thane Dist. during the year 201617. It launched a new range of Diabetic Hypertensive drugs including Voglibose, Glime range (Glimepiride + Metformin +Pioglitazone), Hypernorm range (Telmisartan). The Company further acquired 52,50,000 Equity shares of Rs 10/ each of Resonance Specialties Limited and became its subsidiary effective from 11th December, 2020. During 202021, the Company started manufacturing new ophthalmic eye drops at Naroda, in Ahmedabad in February, 2021. It started work on upgradation / modernization/capacity enhancement of its old liquid injectable manufacturing unit at Naroda, Gujarat in January, 2022.
Read More

Makers Laboratories Ltd FAQs

You can easily buy Makers Laboratories Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -